(Q45639325)

14 December 2017

A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model (English)

1 reference

14 December 2017

Kiyoko Iwatsuki-Horimoto

series ordinal

3

object named as

Kiyoko Iwatsuki-Horimoto

1 reference

14 December 2017

4

Yoshihiro Kawaoka

1 reference

14 December 2017

2

Ayato Takada

1 reference

14 December 2017

Taisuke Horimoto

1

1 reference

PubMed ID

15149783

14 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

14 December 2017

1 reference

14 December 2017

22

1 reference

14 December 2017

17-18

1 reference

14 December 2017

2244-2247

1 reference

Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines

14 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

Live attenuated vaccines against influenza; an historical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

Generation of influenza A viruses with chimeric (type A/B) hemagglutinins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

The NB Protein of Influenza B Virus Is Not Necessary for Virus Replication In Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

Generation of influenza A viruses entirely from cloned cDNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1 /80 (H7N7) influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

Heterologous protection against influenza by injection of DNA encoding a viral protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

Pandemic Threat Posed by Avian Influenza A Viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

Human infection with influenza H9N2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.019

10.1016/J.VACCINE.2003.11.019

7 January 2021

Identifiers

DOI

1 reference

14 December 2017

1 reference

PubMed ID

15149783